Cloud-clone
SKU:MAC000Hu22
Monoclonal Antibody to Haptoglobin Related Protein (HPR)
Monoclonal Antibody to Haptoglobin Related Protein (HPR)
Couldn't load pickup availability
;Immunohistochemistry: 5-30µg/mL;
;Immunocytochemistry: 5-30µg/mL;
;Optimal working dilutions must be determined by end user.
Product No.
MAC000Hu22
Organism Species
Homo sapiens (Human)
Source
Monoclonal antibody preparation
Host
Mouse
Potency (Clone Number)
C12
Ig Isotype
IgG2b Kappa
Purification
Protein A + Protein G affinity chromatography
Label
None
Immunogen
PAC000Hu03-Polyclonal Antibody to Haptoglobin Related Protein (HPR)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
1mg/ml
Organism Species More
Rattus norvegicus (Rat)
Applications
WB,IHC
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a mouse monoclonal antibody raised against HPR. It has been selected for its ability to recognize HPR in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.01-3µg/mL;
Immunohistochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Biology of Blood and Marrow Transplantation | Association of Plasma CD163 Concentration with De Novo–Onset Chronic Graft-versus-Host Disease pubmed:28455006 |
| Biology of Blood and Marrow Transplantation | Association of plasma CD163 concentration with de novo-onset chronic graft-versus-host disease 10.1016:j.bbmt.2017.04.019 |
Share
